{"id":522571,"date":"2021-08-03T16:33:11","date_gmt":"2021-08-03T20:33:11","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/"},"modified":"2021-08-03T16:33:11","modified_gmt":"2021-08-03T20:33:11","slug":"paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/","title":{"rendered":"Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOSTON, Aug.  03, 2021  (GLOBE NEWSWIRE) &#8212; Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and\u00a0military use, today announced that Adam Woodrow, President and Chief Commercial Officer, will participate in a panel discussion at the Wedbush PacGrow Healthcare Conference 2021. The discussion will take place on August 11, 2021 at 4:40 p.m. E.T. and focus on <em>Infectious Personality: Challenges and Optimism in Infectious Diseases: A Discussion of Impactful Drug Development, Innovation, and Regulatory Trends in the Space<\/em>.<\/p>\n<p>To access the live webcast of the discussion, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zuiff1fN87FoGwzaf7XttpyTLNF6bVKUzvLt3jroAb0gbAUMoAFUcGNw1g1MuLViCdYotgGd0Abaun2_dAl2iTjDK6RERv-cad0IekTSvtO7PBXJ6W2IU-xqfIg04Xk99NbxtpUGyLNIg8ZqcCvg26xsU_wu6q_Phj8bob6wVvw=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/wedbush39\/panel26\/2582096<\/a><\/p>\n<p>Please connect to the website at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast can be accessed for up to 90 days following the live presentation.<\/p>\n<p>\n        <strong>About Paratek Pharmaceuticals, Inc.\u00a0<br \/><\/strong>Paratek Pharmaceuticals, Inc.\u00a0is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and\u00a0military use.<\/p>\n<p>The Company\u2019s lead commercial product, NUZYRA<sup>\u00ae<\/sup>\u00a0(omadacycline), is\u00a0a once-daily oral and intravenous antibiotic available in the U.S. for the treatment of adults with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Paratek has a collaboration agreement with\u00a0Zai\u00a0Lab for the development and commercialization of omadacycline in the greater\u00a0China\u00a0region and retains all remaining global rights.<\/p>\n<p>Paratek exclusively licensed U.S. rights and rights to the greater China territory for SEYSARA<sup>\u00ae<\/sup> (sarecycline), a once-daily oral therapy for the treatment of moderate to severe acne vulgaris, to\u00a0Almirall, LLC\u00a0(Almirall). Paratek retains the development and commercialization rights for sarecycline in the rest of the world.<\/p>\n<p>In 2019, Paratek was awarded a contract from BARDA, valued at ~$285 million,\u00a0to support the development and U.S.-based manufacturing of NUZYRA for the treatment of pulmonary anthrax.<\/p>\n<p>For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DYg_eRdIeqhWr4qUgk5wnLpiugajGeoTVeuZuMw0NWgciPFTMr9UC-nnImbwWNkxD5I_2ubFj-qFJwESYctvijsD2oAKCiPMFgp9pijRFtUYxTBQVBuLL9uO2FnSmndppUJ9LeflJlMHMyr2Fk_oV8oLwv2VRNi-cxJNCS2lO1YA3Obo8TJijOQZp0hExAgufLFkb4AKcTvxodGPKCCGx2B11BttRipo9zR17m89pDbSiXer5to1NYSPbjkF3uh6N_JuZLz9TyTCEVGJo9dLvw==\" rel=\"nofollow noopener\" target=\"_blank\">www.ParatekPharma.com<\/a>\u00a0or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-hSQx1U2N_uMrroShPSVXHK6Ny0SKI0cP-mXRuIcXkqPczFkJrBnIW7267un0zLi9exWolKLAyYKyItjN9aZKLW1CZkDZfcuqltfXhf_R7Pz6qEspmdrNghvn6vNOkJuNTZIaRtptCxr90VxDdP_Og==\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rUPBE1KXZ25b5qMJ-6MHEuScqi86xnTZ0_CPwHDabzPdU9bOF--xYWnYveV2z6sjcGk0LUAp_-iZEeYfT27Vjw==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>.<\/p>\n<p>\n        <strong>Forward Looking Statements\u00a0<br \/><\/strong>This press release contains forward-looking statements, including regarding validation of the potential clinical utility of NUZYRA to help address public health emergencies including protecting our civilian and military personnel as a medical countermeasure, including pandemics. All statements, other than statements of historical facts, included in this press release are forward-looking statements, and are identified by words such as &#8220;advancing,&#8221; &#8220;expect,&#8221; &#8220;look forward,&#8221; &#8220;anticipate,&#8221; &#8220;continue,&#8221; and other words and terms of similar meaning. These forward-looking statements are based upon our current expectations and involve substantial risks and uncertainties. We may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in our forward-looking statements and you should not place undue reliance on these forward-looking statements. Our actual results and the timing of events could differ materially from those included in such forward-looking statements as a result of these risks and uncertainties. These and other risk factors are discussed under &#8220;Risk Factors&#8221; and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2020 and our other filings with the Securities and Exchange Commission. We expressly disclaim any obligation or undertaking to update or revise any forward-looking statements contained herein.<\/p>\n<p>\n        <strong>For Investors:\u00a0<br \/><\/strong>Hans Vitzthum <br \/>LifeSci Advisors\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qSzei3NmfYyFCDLWXZFj0MkmN8h_JqOHs9b8w4QXtbauauXFSBJ8-MFb7u8vNDcZ9J_oCdiCYvJQZaZ3I1j9mmvLfFh-7Q80WS_oLlNGisE=\" rel=\"nofollow noopener\" target=\"_blank\">ir@ParatekPharma.com<\/a>\u00a0<br \/>Phone: 617-430-7578<\/p>\n<p>\n        <strong>For Media:\u00a0<br \/><\/strong>Beth Kramli <br \/>Scient PR\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=I4hbsK4tJWsLVlMxeeNZ6r-NrmLWoSO4FAYOK2w9aZslVVxN1vkD92yBrBU7eW3sW_f-P8tnL9xnLTrIr36lGw==\" rel=\"nofollow noopener\" target=\"_blank\">Beth@scientpr.com<\/a>\u00a0<br \/>Phone: 908-568-9721\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTg1NSM0MzM4NzQ1IzIwMjg2ODQ=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/f030bcec-7197-4066-88ef-f7fd61f19525\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Aug. 03, 2021 (GLOBE NEWSWIRE) &#8212; Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and\u00a0military use, today announced that Adam Woodrow, President and Chief Commercial Officer, will participate in a panel discussion at the Wedbush PacGrow Healthcare Conference 2021. The discussion will take place on August 11, 2021 at 4:40 p.m. E.T. and focus on Infectious Personality: Challenges and Optimism in Infectious Diseases: A Discussion of Impactful Drug Development, Innovation, and Regulatory Trends in the Space. To access the live webcast of the discussion, please visit: https:\/\/wsw.com\/webcast\/wedbush39\/panel26\/2582096 Please connect to the website at least 15 minutes prior &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-522571","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Aug. 03, 2021 (GLOBE NEWSWIRE) &#8212; Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and\u00a0military use, today announced that Adam Woodrow, President and Chief Commercial Officer, will participate in a panel discussion at the Wedbush PacGrow Healthcare Conference 2021. The discussion will take place on August 11, 2021 at 4:40 p.m. E.T. and focus on Infectious Personality: Challenges and Optimism in Infectious Diseases: A Discussion of Impactful Drug Development, Innovation, and Regulatory Trends in the Space. To access the live webcast of the discussion, please visit: https:\/\/wsw.com\/webcast\/wedbush39\/panel26\/2582096 Please connect to the website at least 15 minutes prior &hellip; Continue reading &quot;Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-03T20:33:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTg1NSM0MzM4NzQ1IzIwMjg2ODQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021\",\"datePublished\":\"2021-08-03T20:33:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\\\/\"},\"wordCount\":579,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTg1NSM0MzM4NzQ1IzIwMjg2ODQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\\\/\",\"name\":\"Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTg1NSM0MzM4NzQ1IzIwMjg2ODQ=\",\"datePublished\":\"2021-08-03T20:33:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTg1NSM0MzM4NzQ1IzIwMjg2ODQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTg1NSM0MzM4NzQ1IzIwMjg2ODQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/","og_locale":"en_US","og_type":"article","og_title":"Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021 - Market Newsdesk","og_description":"BOSTON, Aug. 03, 2021 (GLOBE NEWSWIRE) &#8212; Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and\u00a0military use, today announced that Adam Woodrow, President and Chief Commercial Officer, will participate in a panel discussion at the Wedbush PacGrow Healthcare Conference 2021. The discussion will take place on August 11, 2021 at 4:40 p.m. E.T. and focus on Infectious Personality: Challenges and Optimism in Infectious Diseases: A Discussion of Impactful Drug Development, Innovation, and Regulatory Trends in the Space. To access the live webcast of the discussion, please visit: https:\/\/wsw.com\/webcast\/wedbush39\/panel26\/2582096 Please connect to the website at least 15 minutes prior &hellip; Continue reading \"Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-03T20:33:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTg1NSM0MzM4NzQ1IzIwMjg2ODQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021","datePublished":"2021-08-03T20:33:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/"},"wordCount":579,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTg1NSM0MzM4NzQ1IzIwMjg2ODQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/","name":"Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTg1NSM0MzM4NzQ1IzIwMjg2ODQ=","datePublished":"2021-08-03T20:33:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTg1NSM0MzM4NzQ1IzIwMjg2ODQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTg1NSM0MzM4NzQ1IzIwMjg2ODQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-wedbush-pacgrow-healthcare-conference-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Paratek Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=522571"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522571\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=522571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=522571"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=522571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}